Contact hypersensitivity is characterized by an antigen-specific T cell-mediated skin inflammation that occurs at the site of challenge with a hapten in individuals who have already generated an immune response to that hapten. A complex cascade follows ultraviolet irradiation of the skin and topical application of a hapten, ending in suppression of the contact hypersensitivity response. A variety of photoreceptors at the body surface initiate the process: these have been identified as DNA, trans-urocanic acid and membrane components. Secondary steps follow, such as the production of a range of soluble immune mediators and changes in the number, phenotype and function of Langerhans cells, dendritic cells and macrophages. The final effector mechanisms include the expression of immunosuppressive cytokines, a change from a type 1 cytokine profile to type 2, the induction of hapten-specific T-regulatory cells and defective antigen presentation. The consequences of immunomodulation for skin cancer are considered. Finally, knowledge regarding ultraviolet-induced immunomodulation is applied to phototherapy for psoriasis and several questions requiring further investigation are identified.
No takes yet. Share an insight, caveat, or question.
Mary Norval (2006) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: